Lakshmana Yenumula has extensive experience in regulatory affairs within the pharmaceutical industry. As the Head of Regulatory Affairs at Somerset Therapeutics Limited since July 2013, Lakshmana is responsible for the planning, execution, and submission of Abbreviated New Drug Applications (ANDAs) for the US market. Prior to this role, Lakshmana served as Assistant Manager of Regulatory Affairs at Panacea Biotec Ltd from February 2010 to July 2013, focusing on dossier preparation and submission for various global markets. Lakshmana's career began at Aurobindo Pharma, where responsibilities included CMC documentation review and regulatory compliance from June 2005 to January 2010, and a role in production at Qualicare Pharmaceuticals Ltd from January 2004 to March 2005. Lakshmana holds a Bachelor of Pharmacy degree from JSS College of Pharmacy, Mysore.